QUIDEL CORPORATION
NASDAQ: QDEL (QuidelOrtho Corporation)
Last update: 8 hours ago13.67
0.54 (4.11%)
| Previous Close | 13.13 |
| Open | 13.33 |
| Volume | 2,150,325 |
| Avg. Volume (3M) | 2,297,691 |
| Market Cap | 932,170,880 |
| Price / Earnings (Forward) | 7.23 |
| Price / Sales | 0.360 |
| Price / Book | 0.520 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2026 |
| Profit Margin | -12.97% |
| Operating Margin (TTM) | 7.03% |
| Diluted EPS (TTM) | -5.23 |
| Quarterly Revenue Growth (YOY) | -2.60% |
| Total Debt/Equity (MRQ) | 90.01% |
| Current Ratio (MRQ) | 1.20 |
| Operating Cash Flow (TTM) | 149.30 M |
| Levered Free Cash Flow (TTM) | 297.44 M |
| Return on Assets (TTM) | 1.12% |
| Return on Equity (TTM) | -11.38% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | QuidelOrtho Corporation | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | 0.75 |
|
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 0.92% |
| % Held by Institutions | 112.82% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Newtyn Management, Llc | 31 Mar 2026 | 4,558,472 |
| Rubric Capital Management Lp | 31 Mar 2026 | 3,306,281 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |